The changing landscape of LDL lowering drugs
For most people, statins are still the best way to lower harmful LDL cholesterol. But two newer drugs may be promising additions or alternatives for those with stubbornly high LDL levels. Bempedoic acid, which lowers LDL by about 25%, works in a manner similar to statins but may help reduce muscle-related side effects seen with statins. Inclisiran interferes with a protein that’s involved with regulating LDL production in the liver; it lowers LDL by about 50%.
Content restricted. Requires subscription